Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis

Zhong Jin, Naijin Xu, Kai Guo, Peng Xu, Pengju Li, Yiming Zhang, Xiezhao Li, Shaobo Zheng, Chunxiao Liu, Abai Xu, Peng Huang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Metastasis-associated in colon cancer-1 (MACC1) expression in tumor specimens is an independent prognostic indicator of metastasis, which has recently gained considerable attention in cancer research, due to its overexpression in several types of carcinoma. However, MACC1 expression patterns and its possible role in renal cell carcinoma remain unknown. This study aimed to investigate MACC1 expression in renal cell carcinoma via immunohistochemical analysis and determine the relationship between MACC1 expression and cancer prognosis. Positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage (P > 0.05). A Kaplan-Meier survival analysis revealed that patients with higher MACC1 expression had a significantly lower disease-free rate (P > 0.05). These results indicate that MACC1 expression is significantly associated with prognosis in patients with renal cell carcinoma. To the best of our knowledge, this is the first study on the significance of MACC1 as a prognostic marker in renal cell carcinoma. MACC1 expression may be a useful target for the development of new therapeutic approaches, including molecular targeted therapeutic agents, for renal cell carcinoma.

Original languageEnglish
Pages (from-to)3857-3863
Number of pages7
JournalInternational Journal of Clinical and Experimental Pathology
Volume8
Issue number4
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Colonic Neoplasms
Neoplasm Metastasis
Renal Cell Carcinoma
Renal cell carcinoma 1
Neoplasms
Kaplan-Meier Estimate
Survival Analysis
Carcinoma
Therapeutics

Keywords

  • Biomarker
  • MACC1
  • Prognosis
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology

Cite this

Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis. / Jin, Zhong; Xu, Naijin; Guo, Kai; Xu, Peng; Li, Pengju; Zhang, Yiming; Li, Xiezhao; Zheng, Shaobo; Liu, Chunxiao; Xu, Abai; Huang, Peng.

In: International Journal of Clinical and Experimental Pathology, Vol. 8, No. 4, 2015, p. 3857-3863.

Research output: Contribution to journalArticle

Jin, Zhong ; Xu, Naijin ; Guo, Kai ; Xu, Peng ; Li, Pengju ; Zhang, Yiming ; Li, Xiezhao ; Zheng, Shaobo ; Liu, Chunxiao ; Xu, Abai ; Huang, Peng. / Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis. In: International Journal of Clinical and Experimental Pathology. 2015 ; Vol. 8, No. 4. pp. 3857-3863.
@article{c0d3e534b00645a5b3a62f2675633439,
title = "Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis",
abstract = "Metastasis-associated in colon cancer-1 (MACC1) expression in tumor specimens is an independent prognostic indicator of metastasis, which has recently gained considerable attention in cancer research, due to its overexpression in several types of carcinoma. However, MACC1 expression patterns and its possible role in renal cell carcinoma remain unknown. This study aimed to investigate MACC1 expression in renal cell carcinoma via immunohistochemical analysis and determine the relationship between MACC1 expression and cancer prognosis. Positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage (P > 0.05). A Kaplan-Meier survival analysis revealed that patients with higher MACC1 expression had a significantly lower disease-free rate (P > 0.05). These results indicate that MACC1 expression is significantly associated with prognosis in patients with renal cell carcinoma. To the best of our knowledge, this is the first study on the significance of MACC1 as a prognostic marker in renal cell carcinoma. MACC1 expression may be a useful target for the development of new therapeutic approaches, including molecular targeted therapeutic agents, for renal cell carcinoma.",
keywords = "Biomarker, MACC1, Prognosis, Renal cell carcinoma",
author = "Zhong Jin and Naijin Xu and Kai Guo and Peng Xu and Pengju Li and Yiming Zhang and Xiezhao Li and Shaobo Zheng and Chunxiao Liu and Abai Xu and Peng Huang",
year = "2015",
language = "English",
volume = "8",
pages = "3857--3863",
journal = "International Journal of Clinical and Experimental Pathology",
issn = "1936-2625",
publisher = "e-Century Publishing Corporation",
number = "4",

}

TY - JOUR

T1 - Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis

AU - Jin, Zhong

AU - Xu, Naijin

AU - Guo, Kai

AU - Xu, Peng

AU - Li, Pengju

AU - Zhang, Yiming

AU - Li, Xiezhao

AU - Zheng, Shaobo

AU - Liu, Chunxiao

AU - Xu, Abai

AU - Huang, Peng

PY - 2015

Y1 - 2015

N2 - Metastasis-associated in colon cancer-1 (MACC1) expression in tumor specimens is an independent prognostic indicator of metastasis, which has recently gained considerable attention in cancer research, due to its overexpression in several types of carcinoma. However, MACC1 expression patterns and its possible role in renal cell carcinoma remain unknown. This study aimed to investigate MACC1 expression in renal cell carcinoma via immunohistochemical analysis and determine the relationship between MACC1 expression and cancer prognosis. Positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage (P > 0.05). A Kaplan-Meier survival analysis revealed that patients with higher MACC1 expression had a significantly lower disease-free rate (P > 0.05). These results indicate that MACC1 expression is significantly associated with prognosis in patients with renal cell carcinoma. To the best of our knowledge, this is the first study on the significance of MACC1 as a prognostic marker in renal cell carcinoma. MACC1 expression may be a useful target for the development of new therapeutic approaches, including molecular targeted therapeutic agents, for renal cell carcinoma.

AB - Metastasis-associated in colon cancer-1 (MACC1) expression in tumor specimens is an independent prognostic indicator of metastasis, which has recently gained considerable attention in cancer research, due to its overexpression in several types of carcinoma. However, MACC1 expression patterns and its possible role in renal cell carcinoma remain unknown. This study aimed to investigate MACC1 expression in renal cell carcinoma via immunohistochemical analysis and determine the relationship between MACC1 expression and cancer prognosis. Positive MACC1 expression was found to significantly correlate with distant metastasis and TNM stage (P > 0.05). A Kaplan-Meier survival analysis revealed that patients with higher MACC1 expression had a significantly lower disease-free rate (P > 0.05). These results indicate that MACC1 expression is significantly associated with prognosis in patients with renal cell carcinoma. To the best of our knowledge, this is the first study on the significance of MACC1 as a prognostic marker in renal cell carcinoma. MACC1 expression may be a useful target for the development of new therapeutic approaches, including molecular targeted therapeutic agents, for renal cell carcinoma.

KW - Biomarker

KW - MACC1

KW - Prognosis

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84935495337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84935495337&partnerID=8YFLogxK

M3 - Article

C2 - 26097569

AN - SCOPUS:84935495337

VL - 8

SP - 3857

EP - 3863

JO - International Journal of Clinical and Experimental Pathology

JF - International Journal of Clinical and Experimental Pathology

SN - 1936-2625

IS - 4

ER -